Genomics Services Market

Best Price Guarantee	Length	Publisher	Published Date	SKU
from $4,850	165 Pages	Fortune Business Insights Pvt. Ltd.	October, 2024	FOB19224253

Best Price Guarantee
Price	from $4,850
Length	165 Pages
Publisher	Fortune Business Insights Pvt. Ltd.
Published Date	October, 2024
SKU	FOB19224253

Genomics Services Market

Growth Factors of Genomics Services Market

The genomics services market size was valued at USD 8.06 billion in 2023, and the market is now projected to grow from USD 8.87 billion in 2024 to USD 22.82 billion by 2032, exhibiting a CAGR of 12.5% during the forecast period of 2024-2032.

The genomics services market growth declined due to the COVID-19 pandemic globally compared to the year 2019 by 5.9%. Such a decrease was mainly achieved through a reduction in the research activities under the categories of cancer and molecular medicine. However, though with the introduction of PCR and NGS in diagnosing COVID-19, growth happened in the later part of the year 2020. This has been evidenced that the market is going to be full of potential growth. The recovery is expected as studying activities are resumed and intensified.

With the development in medical science and research, there has been an increased incidence of molecular diseases such as cancer and other inherited diseases which necessitate genomic services. Genomic diagnostic tests play a great role in the early stages of evaluation and treatment of such disorders. Whole genome sequencing supports the identification of specific mutations in cancer tissues. Another factor that contributes to the necessity of genomic testing is the advancement of precision medicine. Furthermore, developments of the governments and COVID-19 have improved the availability of genomic services to the people, which in turn, have helped in improving the genomic services market share.

Also, the concept of precision medicine brings disease prevention and contrasting therapies closer to patients given their genetics, lifestyles and environments. Regarding chronic diseases, one can observe the trend of increasing popularity of individualized treatments among physicians. Such partnerships were that of Illumina with Janssen Biotech are established to address the rising need for such treatments. The development in genomics is also progressing at a faster rate while the cost of genetic testing is diminishing making it manageable. Such a transition is possibly to create a platform for the uptake of precision medicine across the world.

Comprehensive Analysis of Genomics Services Market

The genomics services market and the healthcare industry are growing exponentially because of market segmentation. This market expansion offers a comprehensive analysis of the various regions taking into account the key supply and demand dynamics that characterize the healthcare IT market. Such segmentations are systematically classified based on service type, technology, application and end user. The service types include, Gene Expression Services (RNASeq), Epigenomics Services, Genotyping, Next-generation Sequencing, Sanger Sequencing and Others. The technology include, Polymerase Chain Reaction (PCR), Next-generation Sequencing (NGS), Microarray, Sanger Sequencing and Others. The application include, Diagnostics, Research and Others. The end-user include, Research Institutes, Healthcare Facilities & Diagnostic Centers, Pharmaceutical & Biotechnological Companies and Contract Research Organization (CRO)).

The North America genomics services market was valued at USD 3.23 billion in 2023. Growth in the region is driven by adequate U.S. reimbursement policies, high per capita spending on advanced therapies and increasing government initiatives supporting genomics research. These factors contribute to the strong market presence in North America. The region is expected to maintain steady growth due to continued investment in genomics.

The leading players have a critical specified influence over the entire healthcare industry and mandatory industrial prospectus of the market standards. These players include, Illumina, Inc. (U.S.), QIAGEN (Germany), PerkinElmer Inc. (U.S.), Eurofins Scientific (Luxembourg), Macrogen, Inc. (South Korea), GENEWIZ (Germany), LGC Limited (U.K.), Q2 Solutions (U.S.) and Bio Rad Laboratories, Inc. (U.S.). These market players offer a level playing competition.

In March 2024, Azenta Life Sciences launched the GENEWIZ Multiomics & Synthesis Solutions facility in Oxford, in the U.K.

Segmentation Table

Global Genomics Services Market Scope

Study Period 2019-2032

Base Year 2023

Forecast Period 2024-2032

Growth Rate CAGR of 12.5% from 2024 to 2032

Historical Period 2019-2022

Unit Value (USD Billion)

Segmentation By Service Type, Technology, Application, End-user, and Region

By Service Type

Gene Expression Services (RNASeq)

Epigenomics Services
Genotyping
Next-generation Sequencing
Sanger Sequencing
Others

By Technology

Polymerase Chain Reaction (PCR)

Next-generation Sequencing (NGS)
Microarray
Sanger Sequencing
Others

By Application

Diagnostics

Research
Others

By End- User

Research Institutes

Healthcare Facilities & Diagnostic Centers
Pharmaceutical & Biotechnological Companies
Contract Research Organization (CROs)

By Region

North America (By Service Type, By Technology, By Application, By End-user, and By Country)

U.S.
Canada
Europe (By Service Type, By Technology, By Application, By End-user, and By Country/ Sub-region)
U.K.
Germany
France
Italy
Spain
Scandinavia
Rest of Europe
Asia Pacific (By Service Type, By Technology, By Application, By End-user, and By Country/ Sub-region)
Japan
China
India
Australia
Singapore
South Korea
Rest of Southeast Asia
Rest of Asia Pacific
Latin America (By Service Type, By Technology, By Application, By End-user, and By Country/ Sub-region)
Brazil
Mexico
Rest of Latin America
Middle East & Africa (By Service Type, By Technology, By Application, By End-user, and By Country/ Sub-region)
GCC
South Africa
Rest of Middle East & Africa

Please Note: It will take 5-6 business days to complete the report upon order confirmation.

1. Introduction: 1.1. Research Scope; 1.2. Market Segmentation; 1.3. Research Methodology; 1.4. Definitions and Assumptions
2. Executive Summary
3. Market Dynamics: 3.1. Market Drivers; 3.2. Market Restraints; 3.3. Market Opportunities; 3.4. Market Trends
4. Key Insights: 4.1. Overview of Genomic Projects – For Key Countries; 4.2. Overview of Genomic Services; 4.3. New Product Launches; 4.4. Key Industry Developments – Mergers, Acquisitions, and Partnerships; 4.5. Prevalence of Key Diseases, By Key Country/Region; 4.6. Impact of COVID-19 on Genomics Market
5. Global Genomics Services Market Analysis, Insights and Forecast, 2019-2032: 5.1. Market Analysis, Insights and Forecast – By Service Type; 5.1.1. Gene Expression Services (RNASeq); 5.1.2. Epigenomics Services; 5.1.3. Genotyping; 5.1.4. Next-generation Sequencing (NGS); 5.1.5. Sanger Sequencing; 5.1.6. Others; 5.2. Market Analysis, Insights and Forecast – By Technology; 5.2.1. Polymerase Chain Reaction (PCR); 5.2.2. Next-generation Sequencing (NGS); 5.2.3. Microarray; 5.2.4. Sanger Sequencing; 5.2.5. Others; 5.3. Market Analysis, Insights and Forecast – By Application; 5.3.1. Diagnostics; 5.3.2. Research; 5.3.3. Others; 5.4. Market Analysis, Insights and Forecast – By End-user; 5.4.1. Research Institutes; 5.4.2. Healthcare Facilities & Diagnostic Centers; 5.4.3. Pharmaceutical & Biotechnological Companies; 5.4.4. Contract Research Organization (CROs); 5.5. Market Analysis, Insights and Forecast – By Region; 5.5.1. North America; 5.5.2. Europe; 5.5.3. Asia Pacific; 5.5.4. Latin America; 5.5.5. Middle East & Africa
6. North America Genomics Services Market Analysis, Insights and Forecast, 2019-2032: 6.1. Market Analysis, Insights and Forecast – By Service Type; 6.1.1. Gene Expression Services (RNASeq); 6.1.2. Epigenomics Services; 6.1.3. Genotyping; 6.1.4. Next-generation Sequencing (NGS); 6.1.5. Sanger Sequencing; 6.1.6. Others; 6.2. Market Analysis, Insights and Forecast – By Technology; 6.2.1. Polymerase Chain Reaction (PCR); 6.2.2. Next-generation Sequencing (NGS); 6.2.3. Microarray; 6.2.4. Sanger Sequencing; 6.2.5. Others; 6.3. Market Analysis, Insights and Forecast – By Application; 6.3.1. Diagnostics; 6.3.2. Research; 6.3.3. Others; 6.4. Market Analysis, Insights and Forecast – By End-user; 6.4.1. Research Institutes; 6.4.2. Healthcare Facilities & Diagnostic Centers; 6.4.3. Pharmaceutical & Biotechnological Companies; 6.4.4. Contract Research Organization (CROs); 6.5. Market Analysis, Insights and Forecast – By Country; 6.5.1. U.S.; 6.5.2. Canada
7. Europe Genomics Services Market Analysis, Insights and Forecast, 2019-2032: 7.1. Market Analysis, Insights and Forecast – By Service Type; 7.1.1. Gene Expression Services (RNASeq); 7.1.2. Epigenomics Services; 7.1.3. Genotyping; 7.1.4. Next-generation Sequencing (NGS); 7.1.5. Sanger Sequencing; 7.1.6. Others; 7.2. Market Analysis, Insights and Forecast – By Technology; 7.2.1. Polymerase Chain Reaction (PCR); 7.2.2. Next-generation Sequencing (NGS); 7.2.3. Microarray; 7.2.4. Sanger Sequencing; 7.2.5. Others; 7.3. Market Analysis, Insights and Forecast – By Application; 7.3.1. Diagnostics; 7.3.2. Research; 7.3.3. Others; 7.4. Market Analysis, Insights and Forecast – By End-user; 7.4.1. Research Institutes; 7.4.2. Healthcare Facilities & Diagnostic Centers; 7.4.3. Pharmaceutical & Biotechnological Companies; 7.4.4. Contract Research Organization (CROs); 7.5. Market Analysis, Insights and Forecast – By Country/ Sub-region; 7.5.1. Germany; 7.5.2. U.K.; 7.5.3. France; 7.5.4. Spain; 7.5.5. Italy; 7.5.6. Scandinavia; 7.5.7. Rest of Europe
8. Asia Pacific Genomics Services Market Analysis, Insights and Forecast, 2019-2032: 8.1. Market Analysis, Insights and Forecast – By Service Type; 8.1.1. Gene Expression Services (RNASeq); 8.1.2. Epigenomics Services; 8.1.3. Genotyping; 8.1.4. Next-generation Sequencing (NGS); 8.1.5. Sanger Sequencing; 8.1.6. Others; 8.2. Market Analysis, Insights and Forecast – By Technology; 8.2.1. Polymerase Chain Reaction (PCR); 8.2.2. Next-generation Sequencing (NGS); 8.2.3. Microarray; 8.2.4. Sanger Sequencing; 8.2.5. Others; 8.3. Market Analysis, Insights and Forecast – By Application; 8.3.1. Diagnostics; 8.3.2. Research; 8.3.3. Others; 8.4. Market Analysis, Insights and Forecast – By End-user; 8.4.1. Research Institutes; 8.4.2. Healthcare Facilities & Diagnostic Centers; 8.4.3. Pharmaceutical & Biotechnological Companies; 8.4.4. Contract Research Organization (CROs); 8.5. Market Analysis, Insights and Forecast – By Country/ Sub-region; 8.5.1. Japan; 8.5.2. China; 8.5.3. India; 8.5.4. Australia; 8.5.5. Singapore; 8.5.6. South Korea; 8.5.7. Rest of Southeast Asia; 8.5.8. Rest of Asia Pacific
9. Latin America Genomics Services Market Analysis, Insights and Forecast, 2019-2032: 9.1. Market Analysis, Insights and Forecast – By Service Type; 9.1.1. Gene Expression Services (RNASeq); 9.1.2. Epigenomics Services; 9.1.3. Genotyping; 9.1.4. Next-generation Sequencing (NGS); 9.1.5. Sanger Sequencing; 9.1.6. Others; 9.2. Market Analysis, Insights and Forecast – By Technology; 9.2.1. Polymerase Chain Reaction (PCR); 9.2.2. Next-generation Sequencing (NGS); 9.2.3. Microarray; 9.2.4. Sanger Sequencing; 9.2.5. Others; 9.3. Market Analysis, Insights and Forecast – By Application; 9.3.1. Diagnostics; 9.3.2. Research; 9.3.3. Others; 9.4. Market Analysis, Insights and Forecast – By End-user; 9.4.1. Research Institutes; 9.4.2. Healthcare Facilities & Diagnostic Centers; 9.4.3. Pharmaceutical & Biotechnological Companies; 9.4.4. Contract Research Organization (CROs); 9.5. Market Analysis, Insights and Forecast – By Country/ Sub-region; 9.5.1. Brazil; 9.5.2. Mexico; 9.5.3. Rest of Latin America
10. Middle East & Africa Genomics Services Market Analysis, Insights and Forecast, 2019-2032: 10.1. Market Analysis, Insights and Forecast – By Service Type; 10.1.1. Gene Expression Services (RNASeq); 10.1.2. Epigenomics Services; 10.1.3. Genotyping; 10.1.4. Next-generation Sequencing (NGS); 10.1.5. Sanger Sequencing; 10.1.6. Others; 10.2. Market Analysis, Insights and Forecast – By Technology; 10.2.1. Polymerase Chain Reaction (PCR); 10.2.2. Next-generation Sequencing (NGS); 10.2.3. Microarray; 10.2.4. Sanger Sequencing; 10.2.5. Others; 10.3. Market Analysis, Insights and Forecast – By Application; 10.3.1. Diagnostics; 10.3.2. Research; 10.3.3. Others; 10.4. Market Analysis, Insights and Forecast – By End-user; 10.4.1. Research Institutes; 10.4.2. Healthcare Facilities & Diagnostic Centers; 10.4.3. Pharmaceutical & Biotechnological Companies; 10.4.4. Contract Research Organization (CROs); 10.5. Market Analysis, Insights and Forecast – By Country/ Sub-region; 10.5.1. GCC; 10.5.2. South Africa; 10.5.3. Rest of Middle East & Africa
11. Competitive Analysis: 11.1. Global Market Share Analysis (2023); 11.2. Company Profiles; 11.2.1. QIAGEN; 11.2.1.1. Overview; 11.2.1.2. Products & Services; 11.2.1.3. SWOT Analysis; 11.2.1.4. Recent Developments; 11.2.1.5. Strategies; 11.2.1.6. Financials (Based on Availability); 11.2.2. Illumina, Inc.; 11.2.2.1. Overview; 11.2.2.2. Products & Services; 11.2.2.3. SWOT Analysis; 11.2.2.4. Recent Developments; 11.2.2.5. Strategies; 11.2.2.6. Financials (Based on Availability); 11.2.3. PerkinElmer Genomics; 11.2.3.1. Overview; 11.2.3.2. Products & Services; 11.2.3.3. SWOT Analysis; 11.2.3.4. Recent Developments; 11.2.3.5. Strategies; 11.2.3.6. Financials (Based on Availability); 11.2.4. Eurofins Scientific SE; 11.2.4.1. Overview; 11.2.4.2. Products & Services; 11.2.4.3. SWOT Analysis; 11.2.4.4. Recent Developments; 11.2.4.5. Strategies; 11.2.4.6. Financials (Based on Availability); 11.2.5. Macrogen, Inc.; 11.2.5.1. Overview; 11.2.5.2. Products & Services; 11.2.5.3. SWOT Analysis; 11.2.5.4. Recent Developments; 11.2.5.5. Strategies; 11.2.5.6. Financials (Based on Availability); 11.2.6. LGC Limited; 11.2.6.1. Overview; 11.2.6.2. Products & Services; 11.2.6.3. SWOT Analysis; 11.2.6.4. Recent Developments; 11.2.6.5. Strategies; 11.2.6.6. Financials (Based on Availability); 11.2.7. GENEWIZ, Inc.; 11.2.7.1. Overview; 11.2.7.2. Products & Services; 11.2.7.3. SWOT Analysis; 11.2.7.4. Recent Developments; 11.2.7.5. Strategies; 11.2.7.6. Financials (Based on Availability); 11.2.8. BGI; 11.2.8.1. Overview; 11.2.8.2. Products & Services; 11.2.8.3. SWOT Analysis; 11.2.8.4. Recent Developments; 11.2.8.5. Strategies; 11.2.8.6. Financials (Based on Availability); 12.